APEX AMOXYCILLIN - 200 BROAD-SPECTRUM ANTIBIOTIC TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apex amoxycillin - 200 broad-spectrum antibiotic tablets

dechra veterinary products (australia) pty. ltd. - amoxycillin as amoxycillin trihydrate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 200.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

APEX AMOXYCILLIN - 400 BROAD-SPECTRUM ANTIBIOTIC TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apex amoxycillin - 400 broad-spectrum antibiotic tablets

dechra veterinary products (australia) pty. ltd. - amoxycillin as amoxycillin trihydrate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 400.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

APO-AMOXYCILLIN amoxicillin (as trihydrate) 250mg/5mL powder for suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-amoxycillin amoxicillin (as trihydrate) 250mg/5ml powder for suspension bottle

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 57.8 mg/ml (equivalent: amoxicillin, qty 50 mg/ml) - suspension, powder for - excipient ingredients: saccharin sodium; colloidal anhydrous silica; xanthan gum; sodium citrate dihydrate; sunset yellow fcf; sorbitol; flavour - indications: it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e. coli (see section 5.1 pharmacodynamic properties - microbiology), p. mira

APO-AMOXYCILLIN amoxicillin (as trihydrate)     125mg/5mL powder for suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-amoxycillin amoxicillin (as trihydrate) 125mg/5ml powder for suspension bottle

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 28.9 mg/ml (equivalent: amoxicillin, qty 25 mg/ml) - suspension, powder for - excipient ingredients: sunset yellow fcf; colloidal anhydrous silica; xanthan gum; saccharin sodium; sodium citrate dihydrate; sorbitol; flavour - indications: it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e. coli (see section 5.1 pharmacodynamic properties - microbiology), p. mira

APO-AMOXYCILLIN amoxicillin (as trihydrate) 250 mg capsules blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-amoxycillin amoxicillin (as trihydrate) 250 mg capsules blister pack

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 286.96 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; gelatin; croscarmellose sodium; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see section 5.1 pharmacodynamic properties - microbiology), p. mirabilis and str

APO-AMOXYCILLIN amoxicillin (as trihydrate) 500 mg capsules blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-amoxycillin amoxicillin (as trihydrate) 500 mg capsules blister pack

arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 573.921 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; titanium dioxide; colloidal anhydrous silica; sodium lauryl sulfate; gelatin; croscarmellose sodium; iron oxide black; microcrystalline cellulose; iron oxide red; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; potassium hydroxide - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see section 5.1 pharmacodynamic properties - microbiology), p. mirabilis and str

CLAVUBACTIN S 62.5 MG BROAD SPECTRUM ANTIBIOTIC TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

clavubactin s 62.5 mg broad spectrum antibiotic tablets

le vet beheer b. v. - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 50.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 12.5 mg/tb - antibiotic & related - dog - small or toy | dog - small | dog - toy - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

MOXYLAN READY-TO-USE INJECTION BROAD SPECTRUM ANTIBIOTIC Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

moxylan ready-to-use injection broad spectrum antibiotic

jurox pty limited - amoxycillin as amoxycillin trihydrate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 150.0 mg/ml - antibiotic & related - cat | cattle | dog | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castrate - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

ILIUM AMOXYCILLIN BROAD-SPECTRUM ANTIBIOTIC INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ilium amoxycillin broad-spectrum antibiotic injection

troy laboratories pty ltd - amoxycillin as amoxycillin trihydrate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 150.0 mg/ml - antibiotic & related - cat | cattle | dog | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castrate - actinobacillus equuli | actinobacillus lignieresii | actinomyces bovis | bacillus anthracis | bacterial infection | bordetella spp. | clostridium spp. | corynebacterium spp. | erysipelothrix rhusiopathiae | escherichia coli (e. coli) | fusiformis spp. | fusobacterium necrophorum | haemophilus spp. | moraxella spp. | pasteurella spp. | proteus mirabilis | salmonella spp. | staphylococcus - not penicillin resist | streptococcus spp. | amoxycillin sensitive bacteria | anthrax | associated with viral disease | bacterial canker | bordetella bronchiseptica | clostridium botulinum | clostridium chauvoei | clostridium fallax | clostridium feseri | clostridium hemolyticum | clostridium novyi | clostridium perfringens types | clostridium septicum | clostridium sordelli | clostridium sporogenes | clostridium tetani | excluding penicillin resistant | gram negative organisms | gram positive organisms | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae